Skip to search formSkip to main contentSkip to account menu

BMS-262084

Known as: BMS262084 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

AzetidinesPiperazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Abstract 631: Nonpeptide Factor XIa (FXIa) Inhibitor. In vitro Kinetic Evaluation and in vivo Studies of BMS-262084 on Arterial Thrombosis and Hemostasis in Rabbits
2005
2005
Multiple pathways are involved in the oral absorption of BMS-262084, a tryptase inhibitor, in rats: role of paracellular transport, binding to trypsin, and P-glycoprotein efflux.
BMS-262084 is a potent and selective beta-lactam tryptase inhibitor with therapeutic potential for treating asthma. The oral… 
Highly Cited
2002
Highly Cited
2002
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
2002
2002
A stereoselective synthesis of BMS-262084, an azetidinone-based tryptase inhibitor.
A highly stereoselective synthesis of the novel tryptase inhibitor BMS-262084 was developed. Key to this synthesis was the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)